{"id":{"repo_id":"ohiolink","oai_identifier":"oai:etd.ohiolink.edu:osu1355865894"},"canonical_url":"https://search.dev.ndltd.org/etd/ohiolink/oai:etd.ohiolink.edu:osu1355865894","repository":{"repo_id":"ohiolink","name":"OhioLINK","base_url":"https://etd.ohiolink.edu/acprod/odb_etd/ws/oai/oai"},"display":{"title":"Total Synthesis of Apratoxin A Analogues","abstract":"Apratoxin A is a potent cytotoxic compound that was isolated from the marine cyanobacterium Lygbya majuscula by Moore, Paul, and co-workers and reported in 2001. Structurally, this natural product is a macrocyclic depsipeptide that contains an unprecedented polyketide domain and a heavily methylated polypeptide domain. The biological mode of action of apratoxin A, to date, has not been fully elucidated. In addition, the mode of action cannot be correlated with any of the standard anti-cancer agents in the National Cancer Institute’s library, which suggests a unique mode of action. Herein are reported our efforts towards discovering an apratoxin A analogue that retains its anti-cancer activity, but eliminates its action against normal cells. We have developed an efficient synthetic route towards the oxazoline analogue of apratoxin A that relies upon a late stage installation of the oxazoline moiety. The convergent nature of the synthetic route has provided us with access to several oxazoline analogues that will be assayed for anti-cancer activity. Also, a second generation synthesis of oxazoline analogues has been developed, which shortens the overall synthetic route and eliminates late stage epimerization problems seen in the original synthesis of oxazoline apratoxin A. In addition, we have developed a reliable synthetic route to an oxazoline analogue that contains a polyethylene glycol domain, which terminates with an azide. The azide has been successfully used in a 1,3-dipolar cycloaddition with a biotinylated alkyne, which will be assayed to help determine the molecular targets of apratoxin A. Furthermore, the polyethylene glycol azide provides us with a handle to install additional biological tags.","abstract_html":"Apratoxin A is a potent cytotoxic compound that was isolated from the marine cyanobacterium Lygbya majuscula by Moore, Paul, and co-workers and reported in 2001. Structurally, this natural product is a macrocyclic depsipeptide that contains an unprecedented polyketide domain and a heavily methylated polypeptide domain. The biological mode of action of apratoxin A, to date, has not been fully elucidated. In addition, the mode of action cannot be correlated with any of the standard anti-cancer agents in the National Cancer Institute’s library, which suggests a unique mode of action. Herein are reported our efforts towards discovering an apratoxin A analogue that retains its anti-cancer activity, but eliminates its action against normal cells. We have developed an efficient synthetic route towards the oxazoline analogue of apratoxin A that relies upon a late stage installation of the oxazoline moiety. The convergent nature of the synthetic route has provided us with access to several oxazoline analogues that will be assayed for anti-cancer activity. Also, a second generation synthesis of oxazoline analogues has been developed, which shortens the overall synthetic route and eliminates late stage epimerization problems seen in the original synthesis of oxazoline apratoxin A. In addition, we have developed a reliable synthetic route to an oxazoline analogue that contains a polyethylene glycol domain, which terminates with an azide. The azide has been successfully used in a 1,3-dipolar cycloaddition with a biotinylated alkyne, which will be assayed to help determine the molecular targets of apratoxin A. Furthermore, the polyethylene glycol azide provides us with a handle to install additional biological tags.","abstract_has_math":false,"creators":["Jackel, Matthew D."],"institution":"The Ohio State University","degree_name":"Doctor of Philosophy","degree_level":"doctoral","degree_discipline":"Chemistry","degree_department":null,"school":null,"contributors":["Forsyth, Craig"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2012,"date_issued":"2012","date_published":"2012","updated_at":"2026-07-24T03:36:08Z","subjects":["Chemistry","Organic Chemistry"],"languages":["English"],"rights":["unrestricted","This thesis or dissertation is protected by copyright: all rights reserved. It may not be copied or redistributed beyond the terms of applicable copyright laws."],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"http://rave.ohiolink.edu/etdc/view?acc_num=osu1355865894","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Forsyth, Craig"]},{"key":"dc:creator","label":"Author","values":["Jackel, Matthew D."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2012"]},{"key":"dc:publisher","label":"Institution","values":["The Ohio State University / OhioLINK"]},{"key":"dc:type","label":"Dc Type","values":["Electronic Thesis or Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["doctoral"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["The Ohio State University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Chemistry","Organic Chemistry"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]},{"key":"dc:rights","label":"Dc Rights","values":["unrestricted","This thesis or dissertation is protected by copyright: all rights reserved. It may not be copied or redistributed beyond the terms of applicable copyright laws."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://rave.ohiolink.edu/etdc/view?acc_num=osu1355865894"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Apratoxin A is a potent cytotoxic compound that was isolated from the marine cyanobacterium Lygbya majuscula by Moore, Paul, and co-workers and reported in 2001. Structurally, this natural product is a macrocyclic depsipeptide that contains an unprecedented polyketide domain and a heavily methylated polypeptide domain. The biological mode of action of apratoxin A, to date, has not been fully elucidated. In addition, the mode of action cannot be correlated with any of the standard anti-cancer agents in the National Cancer Institute’s library, which suggests a unique mode of action. Herein are reported our efforts towards discovering an apratoxin A analogue that retains its anti-cancer activity, but eliminates its action against normal cells. We have developed an efficient synthetic route towards the oxazoline analogue of apratoxin A that relies upon a late stage installation of the oxazoline moiety. The convergent nature of the synthetic route has provided us with access to several oxazoline analogues that will be assayed for anti-cancer activity. Also, a second generation synthesis of oxazoline analogues has been developed, which shortens the overall synthetic route and eliminates late stage epimerization problems seen in the original synthesis of oxazoline apratoxin A. In addition, we have developed a reliable synthetic route to an oxazoline analogue that contains a polyethylene glycol domain, which terminates with an azide. The azide has been successfully used in a 1,3-dipolar cycloaddition with a biotinylated alkyne, which will be assayed to help determine the molecular targets of apratoxin A. Furthermore, the polyethylene glycol azide provides us with a handle to install additional biological tags."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf","p.348","12.56 MB"]},{"key":"dc:title","label":"Title","values":["Total Synthesis of Apratoxin A Analogues"]}]}],"canonical_facts":{"dc:contributor":["Forsyth, Craig"],"dc:creator":["Jackel, Matthew D."],"dc:date":["2012"],"dc:description":["Apratoxin A is a potent cytotoxic compound that was isolated from the marine cyanobacterium Lygbya majuscula by Moore, Paul, and co-workers and reported in 2001. Structurally, this natural product is a macrocyclic depsipeptide that contains an unprecedented polyketide domain and a heavily methylated polypeptide domain. The biological mode of action of apratoxin A, to date, has not been fully elucidated. In addition, the mode of action cannot be correlated with any of the standard anti-cancer agents in the National Cancer Institute’s library, which suggests a unique mode of action. Herein are reported our efforts towards discovering an apratoxin A analogue that retains its anti-cancer activity, but eliminates its action against normal cells. We have developed an efficient synthetic route towards the oxazoline analogue of apratoxin A that relies upon a late stage installation of the oxazoline moiety. The convergent nature of the synthetic route has provided us with access to several oxazoline analogues that will be assayed for anti-cancer activity. Also, a second generation synthesis of oxazoline analogues has been developed, which shortens the overall synthetic route and eliminates late stage epimerization problems seen in the original synthesis of oxazoline apratoxin A. In addition, we have developed a reliable synthetic route to an oxazoline analogue that contains a polyethylene glycol domain, which terminates with an azide. The azide has been successfully used in a 1,3-dipolar cycloaddition with a biotinylated alkyne, which will be assayed to help determine the molecular targets of apratoxin A. Furthermore, the polyethylene glycol azide provides us with a handle to install additional biological tags."],"dc:format":["application/pdf","p.348","12.56 MB"],"dc:identifier":["http://rave.ohiolink.edu/etdc/view?acc_num=osu1355865894"],"dc:language":["English"],"dc:publisher":["The Ohio State University / OhioLINK"],"dc:rights":["unrestricted","This thesis or dissertation is protected by copyright: all rights reserved. It may not be copied or redistributed beyond the terms of applicable copyright laws."],"dc:subject":["Chemistry","Organic Chemistry"],"dc:title":["Total Synthesis of Apratoxin A Analogues"],"dc:type":["Electronic Thesis or Dissertation"],"thesis:degree_discipline":["Chemistry"],"thesis:degree_level":["doctoral"],"thesis:degree_name":["Doctor of Philosophy"],"thesis:institution_name":["The Ohio State University"]},"updated_at":"2026-07-24T03:36:08Z"}